Robert Arthur Harrington, a director at $CYTK, sold 450 shares of the company on 04-03-2025 for an estimated $17,743. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.0% of their shares of this class of stock. Following this trade, they now own 14,658 shares of this class of $CYTK stock.
$CYTK Insider Trading Activity
$CYTK insiders have traded $CYTK stock on the open market 41 times in the past 6 months. Of those trades, 0 have been purchases and 41 have been sales.
Here’s a breakdown of recent trading of $CYTK stock by insiders over the last 6 months:
- ROBERT I BLUM (President & CEO) has made 0 purchases and 10 sales selling 123,361 shares for an estimated $5,524,394.
- FADY IBRAHAM MALIK (EVP Research & Development) has made 0 purchases and 19 sales selling 62,608 shares for an estimated $3,087,726.
- ANDREW CALLOS (EVP, Chief Commercial Officer) has made 0 purchases and 6 sales selling 55,001 shares for an estimated $2,431,164.
- WENDALL WIERENGA has made 0 purchases and 3 sales selling 5,936 shares for an estimated $305,785.
- JOHN T HENDERSON sold 1,780 shares for an estimated $89,747
- ROBERT ARTHUR HARRINGTON has made 0 purchases and 2 sales selling 1,350 shares for an estimated $55,993.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CYTK Hedge Fund Activity
We have seen 148 institutional investors add shares of $CYTK stock to their portfolio, and 176 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BANK OF AMERICA CORP /DE/ removed 4,610,302 shares (-95.5%) from their portfolio in Q4 2024, for an estimated $216,868,606
- DEEP TRACK CAPITAL, LP added 1,870,094 shares (+296.9%) to their portfolio in Q4 2024, for an estimated $87,969,221
- PFM HEALTH SCIENCES, LP removed 1,757,192 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $82,658,311
- FMR LLC removed 1,299,568 shares (-10.7%) from their portfolio in Q4 2024, for an estimated $61,131,678
- CAPITAL INTERNATIONAL INVESTORS added 1,096,164 shares (+inf%) to their portfolio in Q4 2024, for an estimated $51,563,554
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,062,136 shares (+11.0%) to their portfolio in Q4 2024, for an estimated $49,962,877
- UBS GROUP AG added 888,440 shares (+283.3%) to their portfolio in Q4 2024, for an estimated $41,792,217
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CYTK Analyst Ratings
Wall Street analysts have issued reports on $CYTK in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 12/18/2024
- H.C. Wainwright issued a "Buy" rating on 11/18/2024
To track analyst ratings and price targets for $CYTK, check out Quiver Quantitative's $CYTK forecast page.
$CYTK Price Targets
Multiple analysts have issued price targets for $CYTK recently. We have seen 2 analysts offer price targets for $CYTK in the last 6 months, with a median target of $93.5.
Here are some recent targets:
- An analyst from Morgan Stanley set a target price of $67.0 on 03/07/2025
- Joseph Pantginis from H.C. Wainwright set a target price of $120.0 on 10/17/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
